Abstract
We studied the clinical characteristics and long term clinical outcome in patients with SSS who had received a dual chamber rate responsive pacemaker (DDDR) for symptomatic bradycardia in our institutions from 1992 to 1998. Patients were eligible if they received a DDDR pacemaker which was capable of providing diagnostic counters for supraventricular tachyarrhythmias and was programmed “ON”. P wave analysis was manually measured by a single investigator. A surface echocardiogram was performed in all patients before implant to assess left atrial size, left ventricular ejection fraction, and left ventricular mass.